Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Retained-Earnings" stands at 43.51 Billion United States Dollars as of 09/30/2025.
As of the end of Novartis AG's third quarter, the item "Retained Earnings" stands at 43.51 Billion USD. This represents an increase of 4.78 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -6.01 percent compared to the value the year prior.
The 1 year change in percent is -6.01.
The 3 year change in percent is -32.59.
The 5 year change in percent is -24.20.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Retained Earnings | 905,699,262,464.00 |
![]() | Johnson & Johnson - Retained Earnings | 486,508,953,600.00 |
![]() | AbbVie Inc - Retained Earnings | 399,570,305,024.00 |
![]() | Roche Holding AG - Retained Earnings | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Retained Earnings | 280,205,508,085.11 |